PPC
BSX icon

Park Place Capital’s Boston Scientific BSX Stock Holding History

Park Place Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555K Buy
13,014
+1,331
+11% +$72.3K 0.09% 142
2026
Q1 		$733K Buy
11,683
+10,826
+1,263% +$866K 0.15% 92
2025
Q4 		$81.7K Buy
857
+66
+8% +$6.47K 0.02% 270
2025
Q3 		$77.2K Hold
791
– – 0.02% 276
2025
Q2 		$82.9K Hold
791
– – 0.02% 281
2025
Q1 		$79.8K Buy
791
+29
+4% +$2.92K 0.02% 287
2024
Q4 		$68.1K Hold
762
– – 0.02% 319
2024
Q3 		$63.9K Hold
762
– – 0.02% 343
2024
Q2 		$58.7K Sell
762
-316
-29% -$23.1K 0.02% 339
2024
Q1 		$73.8K Buy
1,078
+17
+2% +$1.09K 0.03% 350
2023
Q4 		$61.3K Hold
1,061
– – 0.02% 396
2023
Q3 		$56K Buy
+1,061
New +$55.6K 0.02% 453

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Park Place Capital's BSX Position: Q2 2026 in Review

Park Place Capital increased its Boston Scientific (BSX) stake by 11% in Q2 2026, buying an estimated $72.3K and bringing the position to 13,014 shares worth $555K. The position accounts for 0.09% of the portfolio, ranked #142.

Park Place Capital first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $733K in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Park Place Capital held 13,014 shares of Boston Scientific worth $555K as of Q2 2026.
  • Park Place Capital bought 1,331 Boston Scientific shares in Q2 2026, an estimated $72.3K.
  • Boston Scientific made up 0.09% of Park Place Capital's portfolio in Q2 2026, its #142 holding.
  • Park Place Capital first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Park Place Capital's Boston Scientific position peaked at $733K in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.